Author(s): M. Mukkanti Eswarudu, A. Lakshmana Rao, K. Vijay

Email(s): dralrao@gmail.com , eswarmunnangi@gmail.com

DOI: 10.52711/0974-360X.2023.00450   

Address: M. Mukkanti Eswarudu1,2*, A. Lakshmana Rao3*, K. Vijay4,5
1Faculty of Pharmacy, Jawaharlal Nehru Technological University, Kakinada - 533003, Andhra Pradesh, India.
2Vignan Pharmacy College, Vadlamudi 522213, Andhra Pradesh, India.
3V. V. Institute of Pharmaceutical Sciences, Gudlavalleru - 521356, Andhra Pradesh, India.
4University College of Pharmaceutical Sciences, Acharya Nagarjuna University, Nagarjuna Nagar - 522510, Andhra Pradesh, India.
5Quest International University, Perak 30250, Malaysia.
*Corresponding Author

Published In:   Volume - 16,      Issue - 6,     Year - 2023


ABSTRACT:
For the effective assessment of preclinical, biopharmaceutical and clinical pharmacological investigations, selective and sensitive analytical methods for the quantitative evaluation of drugs and their metabolites (analytes) are essential. Using Rilpivirine as an internal standard (IS), a simple, fast, sensitive, precise and accurate high performance liquid chromatographic method for simultaneous determination of Rivaroxaban and Ticagrelor in human plasma was developed. The analytes were extracted using a direct protein precipitation method with acetonitrile from 500µL aliquots of human plasma. The content of the drugs was assessed using a mobile phase consisting of acetonitrile and 0.1% orthophosphoric acid buffer in a 40:60 v/v ratio and with a flow rate of 1.0ml/min, and an injection volume of 10µL. A Kromasil C18 (250×4.6mm; 5µm) analytical column was used for chromatographic separation and the effluents were monitored at 265nm using a photo diode array (PDA) detector.Rivaroxaban, Ticagrelor and Rilpivirine had retention times of 4.716min, 6.396min and 5.405 min, respectively. Rivaroxaban was shown to be linear at concentrations ranging from 0.018µg/mL - 1.80µg/mL, whereas Ticagrelor was found to be linear between 0.020µg/Ml - 2.00µg/mL. The method was validated according to US-FDA guidelines, and the findings satisfied the acceptance criteria. It was successfully used to determine Rivaroxaban and Ticagrelor in human plasma at the same time and this method is applicable for the pre-clinical and clinical estimation of drugs in biological fluids.


Cite this article:
M. Mukkanti Eswarudu, A. Lakshmana Rao, K. Vijay. Bioanalytical RP-HPLC Method for Simultaneous Quantification of Rivaroxaban and Ticagrelor in Spiked Human Plasma: Validation and Stability. Research Journal of Pharmacy and Technology 2023; 16(6):2741-6. doi: 10.52711/0974-360X.2023.00450

Cite(Electronic):
M. Mukkanti Eswarudu, A. Lakshmana Rao, K. Vijay. Bioanalytical RP-HPLC Method for Simultaneous Quantification of Rivaroxaban and Ticagrelor in Spiked Human Plasma: Validation and Stability. Research Journal of Pharmacy and Technology 2023; 16(6):2741-6. doi: 10.52711/0974-360X.2023.00450   Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-6-28


REFERENCES:
1.    Bioanalytical Method Validation- Guidance for Industry, U.S. Department of Health and Human Services, USFDA,2018;1-40.
2.    Duggan, S.T. Rivaroxaban. Am J Cardiovasc Drugs.2012;12(1):57–72.
3.    Anuja Uddhav Deokar, Suhas Siddheshwar, Sudarshan. B. Kakad. Analytical Method Development and Validation of Rivaroxaban- A Review. Research J. Science and Tech. 2020;12(1):36-46.
4.    Satya prasad B, Jayakumar S. Quantification of anticoagulants dabigatran, rivaroxaban, and prasugrel by chromatographic and spectrometric techniques–Review. Asian J Pharm Clin Res.2019;12(4):1-8.
5.    http://www.drugs.com/history/xarelto.html.
6.    https://go.drugbank.com/drugs/DB08816
7.    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727581/
8.    Zhai HB Liu J, Dong ZC, Wang DX, Zhang B. Current use of oral anticoagulants and prognostic analysis in patients with atrial fibrillation undergoing coronary stenting. Chin Med J (Engl).2017;130(12):1418-1423.
9.    Bhavyasri K, Dhana Lakshmi Ch, Sumanth M. Development and validation of ultra violet-visible spectrophotometric method for estimation of Rivaroxaban in spiked human plasma. J. Pharm. Sci. & Res.2020;12(9):1215-1219.
10.    KasadPinaz A., K.S. Muralikrishna. Area Under Curve Spectrophotometric Method for Determination of Rivaroxaban in Bulk and Tablet Formulation and Its Validation. Asian J. Res. Pharm. Sci. 2013;3(3):109-113.
11.    Eswarudu M M, Lalitha Devi A, Pallavi K, Srinivasa Babu, Nandini Priya S, Sabeeha Sulthana SK. Novel validated RP-HPLC method for determination of Rivaroxaban in bulk and its pharmaceutical dosage form. Int. J. Pharm. Sci. Rev. Res. 2020; 64(1): 183-187.
12.    Mustafa Çelebier, Tuba Reçber, Engin Koçak, Sacide Altınoz, Sedef K. Determination of Rivaroxaban in human plasma by solid phase extraction HPLC. J. of Chromato. Sci. 2016; 54(2): 216–220.
13.    Manjunatha D.H. Determination of Rivaroxaban in pure, pharmaceutical formulation and human plasma samples by RP-HPLC. Int. J. Ad Pharm. Ana. 2015;5(3):65-68.
14.    KasadPinaz A., K.S. Muralikrishna. Method Development and Acid Degradation Study of Rivaroxaban by RP-HPLC in bulk. Asian J. Pharm. Ana. 2013; 3(2): 62-65.
15.    Pinaz A. Kasad, K.S. Muralikrishna. Design and Validation of Dissolution Profile of Rivaroxaban by Using RP-HPLC Method in Dosage Form. Asian J. Pharm. Ana. 2013; 3(3): 75-78.
16.    A. H., Shah P.J, Dedhiya P.P, Vyas B A and Shah S. A. Development and validation of a HPTLC method for Rivaroxaban in human plasma for a pharmacokinetic study. Indian Journal of Pharmaceutical Sciences. 2020; 82(2): 315-320.
17.    Omaima J, Shyamala, Sharma J V C. Development and validation of stability indicating UPLC method for the estimation of ticagrelor in bulk and its tablet dosage form. Journal of drug Delivery and Therapeutics. 2019; 9(1-S): 201-205.
18.    Ayushi R. Mehta, Dilip G. Maheshwari. Development and validation of first UV spectrophotometric method and RP-HPLC method for simultaneous estimation of Rivaroxaban and Ticagrelor in synthetic mixture. Global Trends Pharm Sc. 2018; 9(2): 5275-5297.
19.    Bioanalytical method validation, U.S. Department of health and human services, Food and Drug Administration, USA, May 2018; 1-40.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available